{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:09:52Z","timestamp":1790651392344,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1529,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1R01CA10628"],"award-info":[{"award-number":["1R01CA10628"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.bbmt.2010.08.021","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T06:48:13Z","timestamp":1284360493000},"page":"226-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evidence of B Cell Immune Responses to Acute Lymphoblastic Leukemia in Murine Allogeneic Hematopoietic Stem Cell Transplantation Recipients Treated with Donor Lymphocyte Infusion and\/or Vaccination"],"prefix":"10.1016","volume":"17","author":[{"given":"Craig A.","family":"Mullen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Tkachenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-chiao","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.08.021_bib1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.bmt.1702555","article-title":"Donor leukocyte infusions in acute lymphocytic leukemia","volume":"26","author":"Collins","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.08.021_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.08.021_bib3","first-page":"5797","article-title":"Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease","volume":"60","author":"Anderson","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.08.021_bib4","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1182\/blood.V95.7.2426","article-title":"Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease","volume":"95","author":"Anderson","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.08.021_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.bmt.1704883","article-title":"Augmentation of post transplant immunity: antigen encounter at the time of hematopoietic stem cell transplantation enhances antigen-specific donor T-cell responses in the post transplant repertoire","volume":"35","author":"Mori","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.08.021_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bmt.1704021","article-title":"An analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation","volume":"31","author":"Mori","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.08.021_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbmt.2008.02.015","article-title":"High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A\/ARF mutations retain susceptibility to alloreactive T cells","volume":"14","author":"Young","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.08.021_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbmt.2006.09.008","article-title":"Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease","volume":"13","author":"Natzke","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.08.021_bib9","series-title":"Handbook on Genetically Standardized Jax Mice","author":"Green","year":"1991"},{"key":"10.1016\/j.bbmt.2010.08.021_bib10","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2007-02-073031","article-title":"Leukemia stem cells in a genetically defined murine model of blast phase CML","volume":"110","author":"Neering","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.08.021_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.leu.2402446","article-title":"Unique molecular and cellular features of acute myelogenous leukemia stem cells","volume":"16","author":"Jordan","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.08.021_bib12","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1073\/pnas.102583199","article-title":"A murine model of CML blast crisis induced by cooperation between BCR\/ABL and NUP98\/HOXA9","volume":"99","author":"Dash","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2010.08.021_bib13","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1080\/1042819021000002974","article-title":"Characterization of a murine NKT cell tumor previously described as an acute myelogenous leukemia","volume":"43","author":"LaBelle","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2010.08.021_bib14","first-page":"1525","article-title":"Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine","volume":"59","author":"Anderson","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.08.021_bib15","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood.V81.8.1984.1984","article-title":"Autoimmune neutropenia","volume":"81","author":"Shastri","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.08.021_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V91.1.181","article-title":"Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases","volume":"91","author":"Bux","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.08.021_bib17","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1200\/JCO.2007.13.5376","article-title":"Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma","volume":"26","author":"Marcus","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.08.021_bib18","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1200\/JCO.2008.17.1561","article-title":"Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 Study","volume":"27","author":"Hochster","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.08.021_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1158\/0008-5472.CAN-09-2303","article-title":"Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells","volume":"70","author":"Biernacki","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.08.021_bib20","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1158\/0008-5472.CAN-09-3143","article-title":"Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens","volume":"70","author":"Marina","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.08.021_bib21","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1182\/blood-2006-06-030304","article-title":"Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis","volume":"109","author":"Bellucci","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.08.021_bib22","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2009-03-211375","article-title":"Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation","volume":"115","author":"Wadia","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.08.021_bib23","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","article-title":"Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission","volume":"105","author":"Miklos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.08.021_bib24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.moh.0000245689.47333.ff","article-title":"Chronic graft versus host disease","volume":"13","author":"Baird","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2010.08.021_bib25","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1158\/1078-0432.CCR-07-1290","article-title":"High levels of B-cell activating factor in patients with active chronic graft-versus-host disease","volume":"13","author":"Sarantopoulos","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2010.08.021_bib26","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2008-09-177840","article-title":"Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease","volume":"113","author":"Sarantopoulos","year":"2009","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110003782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110003782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:37:28Z","timestamp":1761057448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879110003782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1083879110003782"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.08.021","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence of B Cell Immune Responses to Acute Lymphoblastic Leukemia in Murine Allogeneic Hematopoietic Stem Cell Transplantation Recipients Treated with Donor Lymphocyte Infusion and\/or Vaccination","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}